[{"address1": "200 Summit Drive", "address2": "6th Floor", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "888 229 3682", "website": "https://www.azenta.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jason W. Joseph J.D.", "age": 52, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 544127, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P.  Marotta", "age": 43, "title": "President, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lawrence Y. Lin", "age": 46, "title": "Executive VP & CFO", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Violetta  Hughes", "age": 50, "title": "VP & Chief Accounting Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Paulo", "title": "VP and Chief Information & Digital Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Perron", "title": "Vice President of Financial Planning & Analysis and Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John E. O'Brien", "age": 53, "title": "Senior Vice President of Corporate Development", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Olga  Pirogova", "age": 49, "title": "Senior VP & Chief HR Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J. Robert Woodward", "title": "Senior Vice President of Global Quality & Regulatory", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ginger  Zhou Ph.D.", "age": 46, "title": "Senior VP and GM of the Genewiz Multiomics & Synthesis Solutions", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 2, "compensationRisk": 3, "shareHolderRightsRisk": 6, "overallRisk": 4, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.brooks.com/company/investors", "maxAge": 86400, "priceHint": 2, "previousClose": 45.94, "open": 45.99, "dayLow": 44.44, "dayHigh": 46.4, "regularMarketPreviousClose": 45.94, "regularMarketOpen": 45.99, "regularMarketDayLow": 44.44, "regularMarketDayHigh": 46.4, "exDividendDate": 1638403200, "fiveYearAvgDividendYield": 0.83, "beta": 1.483, "forwardPE": 59.378593, "volume": 552192, "regularMarketVolume": 552192, "averageVolume": 735017, "averageVolume10days": 506650, "averageDailyVolume10Day": 506650, "bid": 44.83, "ask": 45.04, "bidSize": 200, "askSize": 200, "marketCap": 2048053248, "fiftyTwoWeekLow": 38.82, "fiftyTwoWeekHigh": 69.16, "priceToSalesTrailing12Months": 3.1204958, "fiftyDayAverage": 44.553, "twoHundredDayAverage": 51.52065, "currency": "USD", "enterpriseValue": 1644164864, "profitMargins": -0.25014, "floatShares": 35969834, "sharesOutstanding": 45583200, "sharesShort": 4804558, "sharesShortPriorMonth": 4344298, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.105399996, "heldPercentInsiders": 0.02802, "heldPercentInstitutions": 1.1028199, "shortRatio": 4.17, "shortPercentOfFloat": 0.1594, "impliedSharesOutstanding": 45583200, "bookValue": 38.819, "priceToBook": 1.1574229, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -164170000, "trailingEps": -3.09, "forwardEps": 0.42, "enterpriseToRevenue": 2.505, "enterpriseToEbitda": 81.095, "52WeekChange": -0.2733301, "SandP52WeekChange": 0.2764505, "lastDividendValue": 0.1, "lastDividendDate": 1638403200, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "AZTA", "underlyingSymbol": "AZTA", "shortName": "Azenta, Inc.", "longName": "Azenta, Inc.", "firstTradeDateEpochUtc": 791735400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "5e491b20-46a4-3479-b440-50d926899742", "messageBoardId": "finmb_336648", "gmtOffSetMilliseconds": -18000000, "currentPrice": 44.93, "targetHighPrice": 79.0, "targetLowPrice": 48.0, "targetMeanPrice": 56.6, "targetMedianPrice": 51.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 462091008, "totalCashPerShare": 10.14, "ebitda": 20274644, "totalDebt": 58792000, "quickRatio": 3.099, "currentRatio": 4.066, "totalRevenue": 656323008, "debtToEquity": 3.324, "revenuePerShare": 12.343, "returnOnAssets": -0.017280001, "returnOnEquity": -0.0763, "revenueGrowth": -0.013, "grossMargins": 0.40733, "ebitdaMargins": 0.03089, "operatingMargins": -0.06476, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-15"}]